Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Studies from Kyungpook National University, Cancer Research Institute provide new data on cancer gene therapy
June 10th, 2008
Researchers detail in 'Polymorphisms in the survivin gene and the risk of lung cancer,' new data in cancer gene therapy. "Survivin is an apoptosis inhibitor and plays an important role in the development and progression of cancer. Polymorphisms in the survivin gene may influence survivin production or activity, thereby modulating susceptibility to lung cancer," scientists writing in the journal Lung Cancer report. "To test this hypothesis, we investigated the association between survivin polymorphisms and the risk of lung cancer in a Korean population. We first screened for polymorphisms in the survivin gene by direct sequencing of genomic DNA samples from 27...
Source: Cancer Weekly (2008-06-10)
|
